Kidney transplant patients get genetic check for hidden cancer risks
NCT ID NCT05298904
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests kidney transplant patients for genetic mutations that raise the risk of cancer and other diseases. Researchers want to see how common these mutations are and if testing helps guide better cancer screening. About 177 participants from Mayo Clinic are involved, all of whom have received a kidney or kidney-pancreas transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help tailor cancer screening for kidney transplant patients based on their genetic risk.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures genetic mutations and may not directly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic Arizona
Scottsdale, Arizona, 85259, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the choice of anesthesia quiet the Body's surgical stress response?
- A simple blood test could spot kidney transplant rejection early
- Can your gut bacteria change how transplant drugs work?
- Blood test may take the guesswork out of transplant drug dosing
- Immunotherapy may treat skin cancer in kidney transplant patients without rejection
- Could a daily pill shield transplant patients from a common virus?